Vibe Expands California Footprint, Closes Deal For Santa Rosa Cannabis Facility

California cannabis retailer Vibe Bioscience LtdVIBE VBSCF has taken over Ventura Cannabis and Wellness Corp.'s VCAN Santa Rosa, California-based facility.

The Sacramento, California-based company closed the previously announced acquisition of Cathedral Asset Holding Corp.'s (CAHC) distribution and manufacturing assets.

Under the deal, Vibe purchased Cathedral's issued and outstanding shares for CA$333,360.

In return, Ventura obtained 669,398 common shares and 800,000 warrants.

Each warrant allows Ventura to acquire one Vibe's common share at about 60 cents per share, for a one year term.

CAHC's manufacturing license allows Vibe to boost its Hype Cannabis Co. product line, the company noted Thursday.

Separately, Vibe also appointed Gordon D. Anderson to the board of directors. He replaces Jim Meloche.

Anderson, who has more than 45 years of finance experience, currently serves as Freestyle Group of Companies' President.

Meantime, the Vibe reported record after-tax net income during the second quarter, which amounted to $477,814.

In addition, its revenue went up by 83% over the year to $5.7 million for the quarter.

"Vibe's brand is firmly establishing itself in California," the company's CEO, Mark Waldron, said last month. "Some said it couldn't be done, but Vibe's second-quarter results show that a public cannabis company can both grow and be profitable, not in a few years, but right now."

Courtesy image

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsEntrepreneurshipRetail SalesSmall BusinessGeneralCaliforniacannabis industrycannabis salesmarijuanavibe bioscience
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.